Dr. Jason R. Van Tassel, MD

Dr. Van Tassel practices at Center for Dermatology Cosmetic & Laser Surgery-Fremont Office in Fremont, California.

Dr. Van Tassel's NPI, 1225143084, was assigned on August 20, 2006. Dr. Van Tassel graduated from Georgetown University School Of Medicine in 1997. Dr. Van Tassel's California license number on file is A79305.

Dr. Van Tassel's primary practice is Center for Dermatology Cosmetic & Laser Surgery-Fremont Office, at 2557 Mowry Ave, Fremont, CA 94538 in Alameda County. The practice phone is (510) 797-4111.

Dr. Van Tassel's primary practice is Center for Dermatology Cosmetic & Laser Surgery-Fremont Office in Fremont, California. Dr. Van Tassel is also affiliated with Washington Health. The medical group on file is Washington Health Medical Group. Dmand AI also links Dr. Van Tassel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Tassel practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Van Tassel's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Van Tassel is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Van Tassel's licenses on file in 3 states: California, Nevada and Arkansas.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Van Tassel treats.

CMS data shows 2,181 Medicare services from Dr. Van Tassel across 13 procedure codes in 2024, for 1,021 Medicare patients. Medicare paid $201,186 for them.

CMS counts 1,021 Medicare patients who saw Dr. Van Tassel in 2024. The largest group is 65 to 74, with 385 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 42% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Van Tassel's median patient age at 66, with 50% women.

In 2024, Dr. Van Tassel wrote 1,525 Medicare Part D claims for 514 patients. 99% of them were for generic drugs. CMS names the drug for 1,374 of them, across 22 drugs with 11 or more claims each, at $32,792 in total drug cost. In 2023, CMS named 1,136 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Van Tassel for performance year 2024, reported as part of a group. Dr. Van Tassel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Van Tassel as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Van Tassel in 2021. 2021 was the busiest year, with 2. Dr. Van Tassel's most frequent co-authors are Eugene G. Chio, MD, Michael R. Abidin, MD and Ryan S. Nord, MD.

CMS Open Payments shows 72 general payments to Dr. Van Tassel from 12 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 96% of the total. Cogent Therapeutics LLC paid the most, $56,590.

Dr. Van Tassel graduated from Georgetown University School Of Medicine in 1997.

Dr. Van Tassel is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.